Medical Oncologist @DanaFarber ; Co-director, Prostate Cancer Program @Harvard Cancer Consortium; EIC @ASCO Daily News, FCOI https://teapawt.net/t.co/ywWAdZmBWt
Salt Lake City, UT
Joined January 2016
- Tweets15.1K
- Following784
- Followers17.5K
- Likes25.5K
Pinned Tweet
Truly humbled by the support of colleagues across the American Society of Clinical Oncology (@ASCO) global community. Thank you for the trust and encouragement—I’m deeply grateful and excited to serve. @OncoAlert @urotoday @OncBrothers @montypal @DrChoueiri @DrRanaMcKay
Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the @ASCO Nominating Committee seat. Visit asco.org/election to learn more about the candidates and place your vote! Thank you!!
Neeraj Agarwal, MD, FASCO retweeted
🤩Reflecting on the past 10 years as an @ASCO member, I’m grateful for this community!
🙏Honored to receive the FASCO designation! Such a privilege to give back and #volunteer alongside many amazing people for a cause so close to our hearts!
🙏 #ASCO @ASCOTECAG @IMG_Oncologists @montypal @DrChoueiri @OncBrothers @IvyLorena_Md @TiansterZhang @Noha_Soror @ASridharMD @royaryam @SPremji7866 @FernandoDiazMD1 @realbowtiedoc @Doctor_EZ @MazieTsangMD @christinemphmd @GlopesMd @ZiadBakouny @ziremozay @ADESAIONCMD @inimfonjackson @shilpaonc @AndreaNecchi @NarjustFlorezMD @BernabeCarolina @AyeshaButtMD @KarunNeupaneMD @JiazhangXing
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.
Learn more about FASCO distinction: bit.ly/4BvJVrG
Neeraj Agarwal, MD, FASCO retweeted
Celebrating 20 years of Uro Oncology excellence in Atlantic Canada at #ACUOG26
under the leadership of @RicardoARendon @PGrivasMDPhD @neerajaiims @MikeSerzanMD
Thank you!
@TiffanyPizioli
Neeraj Agarwal, MD, FASCO retweeted
At #ESMO26 we introduced a new word, #RIPTAC, JNJ-6143. Introducing another innovation presented @sitcancer yesterday! FIH Investigational combo of Pasritamig our @JNJInnovMed KLK2xCD3 T-cell agent + our PSMA x CD28 co-stim JNJ-9401. Signal 1 & signal 2 together! #MyCompany
Neeraj Agarwal, MD, FASCO retweeted
🇮🇳 Team India has entered the @Uromigos World Cup bringing spirit of innovation to tackle the issue of disparities and access. 🏆
☕ From Mumbai @adidhanawat to Cleveland, join us for Chai Pe Charcha as we explore low-dose immunotherapy and the potential to make bladder cancer care more accessible and affordable!
And what’s Team India without a little Bollywood magic? 🎶🚂 the music and please LIKE ❤️our video below and show us some love 🥰 👇👇👇
#UromigosLive @UroDocAsh
@achoud72 @VivekSubbiah @VedangMurthy @AgrimaMianMD @montypal @neerajaiims @Parminder1699 @sonpavde @scserendipity1 @DrAnshul_Gupta @Garg_H @drgaganprakash @RenuEapen @NehaVapiwala @RamalingamMD @VincentRK @batraatulonc @DrAmitJoshi_TMC @DrGauravNarula @RenoHemonc @PGrivasMDPhD @karima_oualla @crisbergerot @DrYukselUrun @IBCG_BladderCA @BrainTumorDoc @NVijayvergiaMD @NazliDizman @AparnaKamatMD
🇮🇳 Team India is brewing up some competition at the Uromigos World Cup! ☕⚽🏆
It's Chai Pe Charcha time! From Mumbai to Cleveland, Team India is exploring whether low-dose immunotherapy could make cancer treatment more affordable and what it might mean for bladder cancer.
Cheers to the competition! ☕
🎥 : @shilpaonc & @adidhanawat | #UromigosLive
Neeraj Agarwal, MD, FASCO retweeted
#ExerciseOncology is moving beyond research into everyday #CancerCare
The challenge? Making exercise accessible and feasible for all patients
Some thoughts on bridging this gap:
dailynews.ascopubs.org/do/ca…
Neeraj Agarwal, MD, FASCO retweeted
Real-World Data Explores Post-177Lu-PSMA-617 Therapies in Advanced #ProstateCancer.
What works after 177Lu-PSMA-617 in #mCRPC? @xiaoweimd joins @neerajaiims to discuss real-world PRECISION data in 442 patients: median PFS on the next therapy was 10.7 months with an ARPI and 7.2 months with a taxane. #WatchNow on UroToday > bit.ly/47YLAbM
Neeraj Agarwal, MD, FASCO retweeted
SPECIAL EXPERT SESSION WITH INVITED SPEAKER! Join us for a free live session, streamed online, on PARP Inhibitors in Advanced Prostate Cancer. Register today through event page & reserve your spot:cua.org/event/326140We look forward to seeing you live or online!
@neerajaiims
Neeraj Agarwal, MD, FASCO retweeted
That time of year is here again! ⏰ How did it come around so fast? 😅 @ASCO
Time to start preparing those abstracts for #ASCO27!
📍 Chicago | June 4–8, 2027
📝 Abstract deadline: January 26, 2027
Looking forward to another exciting year of science, innovation & collaboration!
Neeraj Agarwal, MD, FASCO retweeted
🧬 Are we underestimating rare prostate cancer histologies simply because we rarely look for them?
nature.com/articles/s41585-0…
Rare prostate cancer histologies: detection, characteristics and treatment
Rare #ProstateCancer histologies comprise less than 5% of cases but represent a clinically important and under-recognized group.
➡️These subtypes often show aggressive behaviour, atypical metastatic patterns and poorer outcomes, while remaining underrepresented in guidelines and trials.
➡️Accurate diagnosis increasingly depends on multiparametric MRI, immunohistochemistry and genomic profiling.
➡️Molecular alterations such as DNA🧬 repair defects, TP53/RB1 loss and mismatch repair deficiency may offer therapeutic opportunities, highlighting the need for subtype-specific evidence and prospective studies.
@bavilima , @UrogerliMD, @katcollmd, @neerajaiims, @PGrivasMDPhD, @Albert0Briganti, @AndreaNecchi, @LiangChengMD, @SpiessPhilippe
@Oncoalert 🚨 #LPCCC27
@Silke_Gillessen
@AOmlin
@ProfKHerrmann
@weoncologists
Neeraj Agarwal, MD, FASCO retweeted
#PROTEUS Substudy Design and Three-Year Event-Free Survival Endpoint.
Mary-Ellen Taplin, MD joins @neerajaiims to discuss the PROTEUS substudy, randomizing 400 high-risk localized prostate cancer patients 3:1 to prostatectomy alone versus six months of apalutamide and ADT, prostatectomy, and six more months of apalutamide and ADT. #WatchNow on UroToday > bit.ly/4z8V2Fu @DanaFarber
Neeraj Agarwal, MD, FASCO retweeted
ADT Class and Cardiovascular Risk: A Large Retrospective Analysis in Prostate Cancer.
Does ADT class affect cardiovascular risk in #ProstateCancer? @OncHahn @UTMDAnderson joins @neerajaiims @DanaFarber to discuss a large real-world analysis of major adverse cardiac events in men receiving androgen deprivation therapy. #WatchNow on UroToday > bit.ly/4ykeNIZ
Neeraj Agarwal, MD, FASCO retweeted
One month to our 5th @SanRaffaeleMI #GURetreat We are ready to open up The doors to global research in GU cancers! @MyUniSR @PGrivasMDPhD @SpiessPhilippe @UroDocAsh @shilpaonc @drenriquegrande @docjavip @Markuseckstein3 @neerajaiims @montypal @MattGalsky @y_loriot @DrShariat @BianchiniGP @CMercinelli @BrigidaMaiorano @Anto_cigliola @Marzia_DelRe and Many more @IBCG_BladderCA @GTumors @OncoAlert @urotoday
Neeraj Agarwal, MD, FASCO retweeted
One of my favorite @ASCO Daily News Podcasts to date brought @batraatulonc @aiims_newdelhi to the microphone to discuss updates from #ASCO26. As we reflect on all the developments in #oncology over this past year, so critical to think about how/if these can be implemented around the world.
@SuyogCancer @Chitrakshi_11 @VedangMurthy @drgaganprakash @tuttsakhil @RanjitKSMD @Dr_Rahul_AIIMS
Listen here: bit.ly/3LSAv4T
Inspiring “Marjorie Beth Salmon Memorial Lecture” at @DanaFarber today by @KMaxwellLab (@UPenn) on inherited susceptibility to #prostatecancer & what it means for screening👇Thank you for a great talk! 🧬 @PCFnews @urotoday @DanaFarber_GU
Neeraj Agarwal, MD, FASCO retweeted
We're almost there! #UromigosLive 2026 in Nashville🎸
Follow the #UroVoices during next week´s meeting for all the great discussions happening in Nashville🇺🇸 plus play by play coverage of the #UromigosCup 🏆
UromigosLive ,where the Global 🌐GU community meets in Nashville for the great discussions on #ProstateCancer , #BladderCancer #KidneyCancer
@Uromigos @tompowles1 @brian_rini @shilpaonc @montypal @TiansterZhang @neerajaiims @katy_beckermann @PGrivasMDPhD @TwoOncDocs @DrKarineTawagi @nataliagandur @Dr_Aggen @AmandaNizamMD @scocmem @lalaniMD @LosUromigos @uromigosjapan
Neeraj Agarwal, MD, FASCO retweeted
The Netherlands 🇳🇱 @LAUrology_NL @MichvdHeijden World Cup #UromigosLive video is going to be difficult to beat. Vote (❤️=vote) for your best video to win the cup. Italy 🇮🇹 tomorrow then Japan 🇯🇵 and China 🇨🇳 !! Previous winners include Los Angeles @montypal @TDorffOnc @neerajaiims @PGrivasMDPhD and 🇺🇸 @DrChoueiri @OncoAlert - can a team outside of USA 🇺🇸 win? Tune into the Live bladder session (2pm EST 13th Nov) - ‘What’s the standard of care in muscle invasive bladder cancer?’ @DrRosenbergMSK @shilpaonc @@MattGalsky @JoshMeeks
The Uromigos World Cup is here! Countries are competing for the ultimate prize: the 🏆!
First up, Team Netherlands 🇳🇱
#UromigosLive
Neeraj Agarwal, MD, FASCO retweeted
#publicationalert #gupath
We review rare prostate cancer histologies—from diagnostic challenges and distinct molecular features to treatment strategies and unmet clinical needs. @NatRevUrol
🔗 nature.com/articles/s41585-0…
Neeraj Agarwal, MD, FASCO retweeted
Beyond surgery in high-risk prostate cancer.
PROTEUS: adding apalutamide + hormone therapy around surgery improved 3-year freedom from recurrence: 63% vs 41%.
PROTEUS/STAMPEDE/ENZARAD: Same drug class, three different answers. Maybe the question is not ‘does it work’ but ‘for whom’.
@EUplatinum @Albert0Briganti @amerseburger @Uroweb @OncoAlert @myESMO #ESMO26 @APCCC_Lugano @OpenMedicineHQ
Neeraj Agarwal, MD, FASCO retweeted
Out now in @TheLancetOncol: biomarker data from TALAPRO-2 (Enza+/Tala) in mCR #ProstateCancer
Key data:
1. 81% concordance b/w ctDNA & tissue
2. Baseline ctDNA- & CTC0 strongly prognostic
3. Conversion of ctDNA & CTC at wk 9 strongly prognostic.
Link 👉 rb.gy/347dc4
Neeraj Agarwal, MD, FASCO retweeted
🗳️ Voting is open for the 2027 @ASCO Election!
Here’s a quick step-by-step:
1⃣Go to asco.org/election and open the voting link
2⃣Log in with your @ASCO membership credentials
3⃣Review the candidates and cast your votes
My endorsement: For Board of Directors – Undesignated Member (4-year term), I’m voting for @montypal
